David Berry, Valo Health CEO (Flagship Pioneering)
In a surprise move, Flagship's Valo Health and Khosla Ventures SPAC call off merger
By most accounts, the biotech sector has boomed throughout the Covid-19 pandemic, particularly for companies looking to go public through a traditional IPO or the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
